Cancer and Blood Diseases Institute

Publications

Abdullah, S; Webster, A; Blackard, JT; Laskin, B; Seif, AE; Mccormack-Spivey, S; Luebbering, N; Walder, T; Hurst, T; Jodele, S; Davies, SM; Sabulski, A. BK Polyomavirus Escapes Immune Response and Prolongs Cell Survival through Interferon-Regulated Gait Complex and Sirtuin Signaling. Transplantation and Cellular Therapy. 2026; 32(2):s537-s538.

Abid, MB; Wudhikarn, K; Ye, Q; Martens, MJ; Mirza, A-S; Gowda, L; Devarakonda, S; Efebera, Y; Boghdadly, ZE; Dandoy, CE; Murthy, HS; Perales, M-A; Huppler, A; Auletta, JJ. Infections in Patients with Relapsed Refractory Multiple Myeloma Receiving Idecabtagene Vicleucel Therapy: A Real-World Analysis from CIBMTR. Transplantation and Cellular Therapy. 2026; 32(2):s420-s421.

Abu-Arja, MH; Rajabi, Z; Mcglynn, MC; Ghebrelul, RT; Zobeck, M; Harasis, S; Arora, J; Zaghloul, MS; Elhemaly, A; Bertrand, K; Finlay, JL; Dhall, G; Nagabushan, S; Abdelbaki, MS. Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. Journal of Neuro-Oncology. 2026; 177(3).

Ahmed, N; Ali, A; Kim, S; Oloyede, T; Bye, M; Gowda, L; Kamble, RT; Mirza, A-S; Nadiminti, KV; Pophali, PA; Pasquini, MC; Ahmed, S; Ganguly, S; Moskop, A. Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma. Transplantation and Cellular Therapy. 2026.

Alexander, JL; Dávila Saldaña, BJ; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, JJ; Ebens, CL; Cowan, MJ; Petrovic, A; Pai, S-Y; Burroughs, LM. Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood advances. 2026; 10(5):1783-1798.

Alkhouli, L; Badia, P; Bakinowski, E; Craddock, J; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Gorfinkel, L; Huber, J; Patel, V; Jodele, S; Wall, S; Epling, P. Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s252-s253.

Al-Samkari, H; Kasthuri, RS; Zhou, JY; Van Doren, LN; Mccrae, KR; Pishko, AM; Hammill, A; Lewandowska, M; Van Thillo, Q; Ibrahim, I; Byrnes, DM; Sukumar, S; Foy, P; Samuelson Bannow, BT. A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders. Expert Review of Hematology. 2026.

Ambrose, EE; Tomlinson, G; Ngoya, PS; Stuber, SE; Latham, TS; Ware, RE; Makubi, AN; Smart, LR. Persistent Splenomegaly is associated with Morbidity in Tanzanian Children with Sickle Cell Anemia: Secondary Analysis of the SPHERE Trial. Acta Haematologica. 2026; 1-18.

Ammari, O; Shah, M; Elgammal, Y; Husami, A; Kalfa, TA; Gollamudi, J. When a Trait Becomes a Disease: A Rare Hematologic Overlap of Sickle Cell Trait and Hereditary Spherocytosis. American Journal of Hematology. 2026; 101(3):601-605.

Anand, NS; Quinn, CT. NICU to neighborhood: structural drivers shape health inequities for preterm infants. Pediatric Research. 2026.

Anandappa, AJ; Xiao, W; Miles, LA. Single cell sequencing in acute myeloid leukemia: Linking genotype to functional phenotype for precision risk stratification and treatment decisions. Human Pathology. 2026; 106174.

Appell, LE; Baggott, C; Nguyen, K; Prabhu, S; Pacenta, H; John, S; Fabrizio, VA; Phillips, CL; Rossoff, J; Talano, J-A; Mackall, CL; Laetsch, TW; Mcnerney, K; Schultz, LM. Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel. Blood advances. 2026; 10(1):106-110.

Armstrong, AE; Gross, AM; Klesse, LJ; Rhodes, SD; Ahlawat, S; Staedtke, V; Molina, CA; Hirbe, AC. Neurofibromatosis type 1-plexiform neurofibromas: Integrating treatment across pediatric and adult populations. Neuro-Oncology. 2026; 28(4):847-863.

Arnold, DE; Kaviany, S; Aluri, J; Calvo, KR; Mehta, SS; Tobin, JM; Schuettpelz, LG; Saucier, N; Schmitz, EG; Murguía-Favela, L; Pai, S-Y; Bednarski, JJ; Connelly, JA; Cooper, MA. Clinical characteristics, management, and hematopoietic cell transplantation of patients with TLR8 gain-of-function. Blood advances. 2026; 10(6):1967-1976.

Arnold, DE; Eissa, H; Dunn, E; Cuvelier, GDE; Wright, NAM; Marsh, RA; Parikh, S; Saldana, BD; Vander Lugt, MT; Bacchetta, R; Torgerson, TR; Leiding, JW; Heimall, J; Chan, AY. IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC). Journal of Allergy and Clinical Immunology: In Practice. 2026.

Arnold, DE; Leiding, JW; Logan, B; Marsh, RA; Griffith, LM; Grunebaum, E; Murguía-Favela, L; Mallhi, K; Chellapandian, D; Deal, CL; Torgerson, T; Malech, HL; Kang, EM; Parikh, S. Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. Transplantation and Cellular Therapy. 2026; 32(1):89.e1-89.e10.

Avery, RA; Gross, AM; Cousineau-Krieger, C; Keenan, TDL; Mcmanus, T; Dallas, CJ; Hampton, C; Baldwin, A; Jin, F; Heisey, K; Bishop, RJ; Fisher, MJ; Widemann, BC; Magone, MT. Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy. Ophthalmology (Rochester, Minn.). 2026; 133(2):291-294.

Awuonda, BO; Kiyaga, C; Chirande, L; Franklin, PC; Nnodu, OE; Ambrose, EE; Dogara, LG; Chunda-Liyoka, CM; Segbefia, CI; Zapfel, A; Berliner, N; Novelli, EM; Coetzer, TL; Ware, RE. Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA). Blood advances. 2026; 10(9):3200-3206.

Babic, I; Bryan, N; Cunningham, C; Sampson, A; Starczynowski, D; Nurmemmedov, E. MICRO-TAG enzyme complementation enables quantification of cellular drug-target engagement in temperature series. SLAS Discovery. 2026; 38:100291.

Badia, P; Alkhouli, L; Bakinowski, E; Blevins, C; Culbertson, C; Dandoy, CE; Davies, SM; Desalvo, AM; Diaz, J; Huber, J; Parker, L; Rotz, SJ; Stuckey, R; Hartley, D. A Day in the Life of the Engraft Learning Network: Bridging Perspectives and Driving Discovery. Transplantation and Cellular Therapy. 2026; 32(2):s513-s514.

Badia, P; Alkhouli, L; Blevins, C; Culbertson, C; Dandoy, CE; Davies, SM; Diaz, J; Hartley, D; Huber, J; Hunter, L; Nguyen, A; O'mathúna, D; Parker, L; Nelson, AS. The Engraft Journey Map: Co-Designing a Roadmap for Patients and Caregivers Undergoing Bone Marrow Transplant. Transplantation and Cellular Therapy. 2026; 32(2):s357-s358.

Badia, P; Langenberg, L; Ibrahimova, A; Jodele, S; Davies, SM; Khandelwal, P. Post-Transplant Cyclophosphamide GVHD Prophylaxis Has a Unique Vascular Toxicity Compared to Abatacept Containing Regimens. Transplantation and Cellular Therapy. 2026; 32(2):s591.

Bajgain, P; Feng, Y; Puebla, M; Tian, M; Hsu, K-S; Lee, J; Yu, G; Yang, L; Seaman, S; Hilton, MB; Khan, J; Nellan, A; Kaplan, RN; St Croix, B. Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy. Cell Reports Medicine. 2026; 7(5):102782.

Bartlett, A; Romero, L; Hunter, G; French, K; Scott, SL; Dorn, K; Davies, SM. Puppy Taails Study: Perceived Utility from Patient and Parent Surveys of Therapeutic Animal Assisted Interventional Services in Pediatric Cancer and Bone Marrow Transplant Patients. Transplantation and Cellular Therapy. 2026; 32(2):s599.

Batschelett, MA; Migneault, KY; Aschbacher-Smith, L; Cecil, KM; Huddleston, DA; Gilbert, DL; Ratner, N; Difrancesco, MW. Multiecho Resting-State Functional Magnetic Resonance Imaging Analysis of Attention-Deficit/Hyperactivity Disorder Severity and Motor Dysfunction in a Pediatric Sample of Neurofibromatosis Type 1. Pediatric Neurology. 2026; 181:136-147.

Belton, T; Carbaugh, L; Stevens, E; Seide, A; Ferreira, B; Teng, O; Bennett, L; Pfeiffer, A; Ferreira, M; Shova, A; Niss, O; Smith-Whitley, K; Jan, S; Steinway, CM. Recruitment and retention of young adults with sickle cell disease. Health Care Transitions. 2026; 4:100133.

Bender, JLG; Pressey, JG; Wagner, LM; Kim, A; Shah, AT; Federico, SM; Morgenstern, DA; Hoogstra, DJ; Crane, J; Bhatt, K; Cai, G; Miao, X; Ma, J; Laetsch, TW. Safety and pharmacokinetics (PK) of lurbinectedin (lurbi) in pediatric patients (pts) with relapsed/refractory (R/R) solid tumors and preliminary antitumor activity in pediatric and young adult pts with R/R Ewing sarcoma (EwS): Results from a phase 1 study. Journal of Clinical Oncology. 2026; 44(16_suppl):11518-11518.

Bender, JD; Pommert, L; Backus, LR; Bidwell, A; Blank, C; Breese, EH; Burns, KC; Lane, A; Lee, LH; Mizukawa, B; Ryan, TD; Young, J; Absalon, M; Perentesis, JP. CPX-351 in High-Risk Relapsed Pediatric Acute Leukemia: Real-World Phase 1 Data Establishing the FDA-Approved Dose. Pediatric Blood and Cancer. 2026; 73(6):e70268.

Betensky, M; Azzam, M; Bercovitz, R; Bhat, RV; Biss, T; Branchford, B; Brandão, LR; Chan, AKC; Faustino, EVS; Hamarsha, Q; Williams, S; Wilson, HP; Woods, G; Mustafa, RA. ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism. Blood advances. 2026; 10(12):4303-4333.

Bischoff, LJ; Sherpa, C; Schrenk, S; Boscolo, E. Constitutive, Mosaic Expression of TIE2 p.L914F During Mouse Development Causes Venous Malformation. The FASEB Journal. 2026; 40(9):e71862.

Biswas, K; Ghosh, S; Khincha, PP; Sundby, T; Singh, A; Ault, G; Henderson, M; Gross, AM; Donoghue, M; Savage, SA; Widemann, BC; Shoemaker, RH; Mohammed, A. Rare cancers research: Current state of knowledge and emerging opportunities for prevention and interception. Journal of the National Cancer Institute. 2026.

Boas, H; Mcdonough, J; Lane, A; Demauro, SB; Ren, CL; Josephson, M; Goldfarb, SB; Robinson, PD; Allen, JL. Normal Values for Respiratory Oscillometry in Pediatrics: An Argument for a Local Control Population. Pediatric Pulmonology. 2026; 61(3):e71508.

Boas, H; Mcdonough, J; Lane, A; Demauro, SB; Ren, CL; Josephson, M; Goldfarb, SB; Robinson, PD; Allen, JL. Cover Image, Volume 61, Number 3, March 2026. Pediatric Pulmonology. 2026; 61(3):i-i.

Boldt, A; Davies, SM; Benoit, SW. Decreased Pre-Transplant Kidney Function Is Associated with Mortality and Dialysis Needs during Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2026; 32(2):s601-s602.

Borogovac, A; Efebera, Y; Clark, L; Houk, A; Ragon, BK; Hamilton, BK; Devine, SM; Dandoy, CE; Plasteras, J; Wall, S; Horowitz, MM; Khera, N; Juckett, MB; Bhatt, N. Clinical Decision-Making in Hematopoietic Cell Transplantation (HCT) for Severe Aplastic Anemia (SAA): Insights from a National Survey of Physicians. Transplantation and Cellular Therapy. 2026; 32(2):s318-s319.

Bota, KE; Young, K; Wall, J; Koo, J; Myers, K; Ramos, KN; Dandoy, CE; Davies, SM; Taggart, CB. Got Nutrition? Exclusion of Nutrition Intervention at Key Points during Hematopoietic Stem Cell Transplantation Negatively Impacts Frailty. Transplantation and Cellular Therapy. 2026; 32(2):s607-s608.

Boucher, AA; Cole, OB; Desai, PC; Donald, C; Fasipe, TA; Quinn, CT; Kennedy Lesch, J; Thompson, AA. ASH's commitment to SCD: building on 10 years of progress. Blood advances. 2026; 10(5):1518-1521.

Brammer, CN; Lee, T; Bahakel, H; Kim, H; Paulsen, GC; Miller-Handley, H; Pommert, L; Danziger-Isakov, LA; Otto, WR. P-522. Epidemiology of respiratory viral infections in pediatric acute leukemia patients. Open Forum Infectious Diseases. 2026; 13(Supplement_1):ofaf695.737.

Brumm, VL; Kidd, SA; Logan, BR; Chunara, F; Heimall, J; Griffith, LM; Kohn, DB; Sanchez, L; Bednarski, JJ; Martinez, C; Pulsipher, MA; Puck, JM; Cowan, MJ; Shah, AJ. Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. Journal of Human Immunity. 2026; 2(1):e20250163.

Cai, P; Liu, J; Xu, H; Wang, X; Zou, C; Zhang, L. LESA: Learnable Stage-Aware Predictors for Diffusion Model Acceleration. . 2026; abs/2602.20497.

Cai, H; Tian, C; Mackie, K; Guo, F. Interfacing biological neural networks with three-dimensional devices. Nature Electronics. 2026; 9(5):461-462.

Cai, M; Duan, X; Jorgensen, R; Wunderlich, M; Guo, F; Zheng, Y. Abstract B013: Targeting CDC42 increases TCF1-mediated “stemness” and rejuvenates human T cells to enhance CAR-T efficacy. Cancer immunology research. 2026; 14(2_Supplement):b013-b013.

Castel, P; Schoyer, L; Stronach, B; Bogdanova, R; Bennett, AM; Blakeley, J; Bornhorst, M; Bowers, T; Brachmann, SM; Burkitt-Wright, E; Traylor, M; Weaver, KN; Yohe, M; Green, T. The 9th International RASopathies Symposium. American Journal of Medical Genetics, Part A. 2026.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, KE; Fisher, KS; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF biomarkers for facilitating diagnosis of CNS-HLH from other neuroinflammatory disorders. Blood advances. 2026; 10(4):960-972.

Chandrakasan, S; Westbrook, A; Griffith, LM; Hagin, D; Iyengar, S; Mangurian, C; Scalchunes, C; Sullivan, KE; Zablocki, A; Bakshi, N; Torgerson, T; Cowan, MJ; Ochs, HD; Parikh, S. Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers. Clinical Immunology. 2026; 283:110658.

Chlon, T. Rescue gone rogue: the ERCC6L2 syndrome and TP53 mutations. Blood. 2026; 147(15):1651-1652.

Clark, A; Blignaut, M; Gerlach, W; Klein, G; Kusnier, K; Maier, S; Mohr, R; Smith, H; Spears, K; Tunningley, O; Grimley, MS. Bridging the Training Gap for Nurses and Advanced Practice Providers: Addition of in-Situ Simulations for Pediatric Transplant and Cellular Therapy Emergencies. Transplantation and Cellular Therapy. 2026; 32(2):s493-s494.

Cook, E; Gloude, N; Bidgoli, A; Krogman, A; Williams, KM; Khandelwal, P. Ruxolitinib as a Steroid-Sparing Treatment for Chronic Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 2026.

Cook, E; Gloude, NJ; Bidgoli, A; Krogman, A; Williams, KM; Khandelwal, P. Ruxolitinib As a Steroid-Sparing Treatment for Chronic Graft Vs Host Disease: A Case Series. Transplantation and Cellular Therapy. 2026; 32(2):s290-s291.

Cook, E; Rotz, SJ; Auletta, JJ; Bidgoli, A; Blacken, R; Johnson, D; Badia, P; French, K; Hartley, DM; Kent, GR; Schoettler, ML; Sampson, M; Dandoy, CE; Fitch, TJ. Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective. Pediatric Blood and Cancer. 2026; 73(3):e70001.

Curlee, MS; Siegel, A; Little, P; Toledo-Tamula, MA; Martin, S; Gross, AM; Yohe, ME; Aryavand, M; Frone, MN; Ney, GM; Stewart, DR; Wolters, PL. Wide Ranging Neurobehavioral Phenotype in Individuals With Costello Syndrome. American Journal of Medical Genetics, Part A. 2026; 200(5):1138-1144.

Daugherty, EC; Zhang, Y; Xiao, Z; Backus, L; Mcdonald, JM; Stockman, B; Woo, J; Mccann, C; Russell, K; Sharma, R; Simone, CB; Breneman, J; Perentesis, JP; Mascia, AE. FAST-02: Results from the second in-human prospective evaluation of single-fraction proton FLASH for symptomatic thoracic bone metastases. Radiotherapy and Oncology. 2026; 111671.

Davies, SM; Blyth, E; Bollard, CM; Craddock, J; Dahi, PB; Gottlieb, D; Grimley, MB; Keller, MD; Khoury, R; Olson, AL; Shpall, EJ; Spivey, SM; Vasileiou, S; Heslop, HE. Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT. Transplantation and Cellular Therapy. 2026.

Dezern, AE; Gillis, N; Otterstatter, M; Abel, G; Padron, E; Deeg, HJ; Al Baghdadi, T; Liu, J; Xie, Z; Zhang, L; Lee, C; Difronzo, N; Walter, M; Sekeres, MA. A novel approach to defining progression in MDS and precursor myeloid conditions in the MDS Natural History Study. Blood advances. 2026; 10(8):2743-2753.

Dorn, L; Dandoy, C; Ryan, TD; Lizardi, JCV. 26-A-15331-ACC PERICARDIAL EFFUSION IS ASSOCIATED WITH CLINICAL AND SUBCLINICAL LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PEDIATRIC PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. Journal of the American College of Cardiology. 2026; 87(13):a1107.

Dorn, LE; Perry, T; Flint, K; Luchtman-Jones, L; Engel, ER. Bivalirudin Monitoring Using Dilute Thrombin Time in Pediatric Extracorporeal Membrane Oxygenation: Single-Center, Retrospective Cost Analysis, 2018-2023. Pediatric Critical Care Medicine. 2026; 27(6):714-721.

Drolet, B; Mack, J; Sisk, B; Al-Huniti, A; Chang, VY; Hammill, A; Iacobas, I; Kelly, M; Mcdermott, S; Winger, BA; Robledo, MA; Blakesley, R; Patriquin, C; Singh, S; Crary, SE. 080 ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation. Journal of Investigative Dermatology. 2026; 146(3):s19.

Drucker, M; Lee, D; Bowman, M; Zhang, X; Kain, BN; Nicolet, D; Bandopadhyay, R; Singh, V; Wang, Z; Stone, RM; Grimes, HL; Eisfeld, A-K; Bowman, RL; Miles, LA. Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis. Blood. 2026; 147(26):3209-3216.

Duong, N; Khan, DH; Thomas, GE; Feng, Y; Hurren, R; Lee, JB; St-Germain, J; Drimmer, L; Yan, Y; Zhang, LX; Jacobs, MG; Goede, D; Spadavecchio, V; Schimmer, AD. Intracellular IL-23R is necessary for mitotic spindle formation and viability in AML. Leukemia. 2026; 40(5):906-917.

El Kassar, N; Dezern, AE; Abkowitz, J; Artz, A; Beerman, I; Bolton, K; Brooks, MM; Borate, U; Ershler, WB; Ganz, T; White, KE; Zhang, D; Ferrucci, L; Kuchel, GA. A proposed path to explaining the unexplained anemia of aging. The journals of gerontology. Series A, Biological sciences and medical sciences. 2026; 81(1).

Ellifson, GK; Dandoy, CE; Fabrizio, VA; Kapadia, M; Lehmann, LE; Olson, KE; Puranik, CP; Treister, N; Thikkurissy, S; Chin, K. Assessment of Oral Health Practices for Patients Receiving Stem Cell Transplantation at Pediatric Oncology Centers. Transplantation and Cellular Therapy. 2026; 32(2):s315-s316.

Eskandari, N; Pappano, E; Ruiz, MAD; Mahmud, N; Ren, G; Ivy, ZK; Gaitonde, S; Gordeuk, VR; Gladwin, MT; Malik, P; Quinn, CT; Saraf, SL. Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell Disease. Blood. 2026.

Faulk, KE; Kairalla, JA; Hibbitts, E; Long-Boyle, J; Devidas, M; August, A; Gore, L; Raetz, E; Hunger, SP; Loh, ML; Teachey, DT; Brown, P; Breese, EH; Kotecha, RS; Guest, E. Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1. Blood advances. 2026; 10(1):70-74.

Fay, ME; Tandon, R; Latham, T; Lee, AJ; Rankine-Mullins, AE; Reid, M; Mitchell, CS; Ware, RE; Lam, WA. Artificial Intelligence-Based Analysis of Central Nervous System Vasculopathy in Pediatric Sickle Cell Anemia. American Journal of Hematology. 2026; 101(5):998-1004.

Ferreira, L; Sorrell, M; Raskin, SI; Kim, SY. DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome. Cancer Genetics. 2026; 302-303:162-165.

Fobare, S; Sharpe, C; Quinn, K; Bryant, K; Miles, LA; Bowman, RL; Cheney, C; Furby, C; Long, M; Fyock, K; Perentesis, JP; Eisfeld, A-K; Hertlein, E; Byrd, JC. Characterization of the clonal hierarchy and immunophenotype of PTPN11 mutations in acute myeloid leukemia. JCI Insight. 2026; 11(4).

Forrest, J; Galea, C; Steinway, C; Teng, O; Chen, J; Jan, S; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Boruchov, D; Nortey, E; Smith-Whitley, K; Trachtenberg, S; Belton, T. Community health worker support to adolescents and young adults with sickle cell disease: A multi-method analysis on transition-related support. Health Care Transitions. 2026; 4:100137.

Galletta, TJ; Rubinstein, JD; Dandoy, CE; Khoury, R; Faulhaber, A; Phillips, CL; Krupski, C. Emapalumab for Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CD19-Directed CAR-T in Two Patients With B-ALL: Clinical and Biomarker Correlates. Pediatric Blood and Cancer. 2026; e70406.

Galletta, TJ; Rubinstein, JD; Krupski, C; Dandoy, CE; Khoury, R; Faulhaber, A; Davies, SM; Phillips, CL. Biomarker Elevations Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome after CD19-Directed CAR-T Therapy in Children and Young Adults with Acute B-Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 2026; 32(2):s177.

Ghalehsari, N; Pandey, M; Auletta, JJ; Beaver, E; Davies, SM; Espinoza-Gutarra, MR; Fraint, E; Holter-Chakrabarty, J; Howard, D; Knutson, J; Ramos, KN; Shah, R; Hall, AG; Gomez-Arteaga, A. Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and Cellular Therapy. 2026; 32(1):12.e1-12.e4.

Gibson, NM; Nguyen, N; Amaral, S; Hsu, J; Haney, M; Heimbruch, KE; Sabulski, A; Zurawel, A; Davidow, KA; Lind, KT; Hall, L; Bailey, LC; Olson, TS; Kwiatkowski, JL. Impact of iron overload on hematopoietic stem cell transplantation in pediatric patients with nonmalignant hematological disorders. Blood advances. 2026; 10(10):3324-3334.

Gilene, S; Miller, C; Cronk, JC; Graham, RT; Gross, AM; Hummel, TR; Kotch, C; Mochizuki, AY; Raskin, S; Pillay-Smiley, N; De Blank, P. MEK inhibitor-induced dropped head syndrome in pediatrics. Neuro-Oncology Pediatrics. 2026; 2(2):wuag024.

Girgis, MK; Lopachin, TR; Hallett, TC; Briones, MA; Desai, NJ; Mcelhinney, KE; Ware, RE; Yee, MEM. Prolonged, Unintentional Overdose of Hydroxyurea in a Child With Sickle Cell Anemia. Pediatric Blood and Cancer. 2026; 73(2):e70076.

Gloude, NJ; Brundige, K; Loveless, S; Atkinson, I; Chandra, S; Cooper, R; Coyne, K; Dusa, C; Galvin, A; Geddis, A; Millecker, J; Walkovich, K; Shimamura, A; Myers, KC. Beyond neutropenia: Immunological evaluation of patients with Shwachman-Diamond syndrome. British Journal of Haematology. 2026.

Goldfarb, SB; Gupta, A; Shanley, R; Josephson, M; Freedman, J; Towe, C; Davies, SM; Myers, K. B105-09 Bridging Diagnostic Gaps in Pediatric BOS: Clinical Relevance of Pediatric ATS BOS Criteria Post-HSCT. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2623.

Gonzalez, CE; Fletcher, A; Jenkins, TL; Zahraeifard, S; Peterson, R; Taylor, M; Jones, C; Urban, A; Avila, D; Campillay, M; Pai, S-Y; Grimley, M; Freeman, AF; Cortese, I. Resolution of PML after Treatment with Virus-Specific T Cells and HCT. New England Journal of Medicine. 2026; 394(20):2061-2064.

Gopalan, L; Na, Y; Hu, L; Hall, A; Kim, M-O; Dombi, E; Szabo, S; Ratner, N; Huang, G; Wu, J. Valosin-Containing Protein Contributes to Plexiform Neurofibroma Formation and Represents a Novel Therapeutic Target. Cells. 2026; 15(9).

Grover, KE; Cappel, ZR; Volz, AM; Cotella, EM; Smallwood, K; Berryhill, CA; Raje, KR; Fisher, AA; Casper, MCT; Nardini, D; Prada, CE; Weaver, KN; Waclaw, RR; Robinson, JE. Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice. HGG Advances. 2026; 7(3):100621.

Gruber, TA; Jeha, S; Deyell, RJ; Lewis, V; Chang, BH; Lowe, EJ; Frediani, J; Vezina, C; Michon, B; Richards, M; Athale, U; Stearns, D; Schiff, D; Gaynon, PS. Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study. The Lancet Haematology. 2026; 13(3):e144-e156.

Grupp, SA; Grimley, MS; Driscoll, T; Mahadeo, KM; Leonard, A; Wang, Y; Phillips, H; Justus, D; Lehmann, LE; Esrick, E; Tisdale, JF; Sharma, A; Crees, ZD; Manis, J. Improved Hematopoietic Stem Cell Mobilization for Gene Therapy of Hemoglobinopathies Using Single Agent Motixafortide. Transplantation and Cellular Therapy. 2026; 32(2):s20-s21.

Guerrettaz, R; Peterson, A; Allbee-Johnson, M; Ahn, KW; Rotz, SJ; Sharma, A; Im, A; Nuechterlein, B; Ahmed, S; Mehta, PA; Phillips, CL; Higgins, R; Broglie, L; Phelan, R. Outcomes of Allogeneic Stem Cell Transplantation In the Adolescent and Young Adult Population with Acute Lymphoblastic Leukemia Based on Transplant Center: A Center for International Blood and Marrow Transplant Research (CIBMTR) Study. Transplantation and Cellular Therapy. 2026; 32(2):s112.

Guilcher, GMT; Dalal, S; Suresh, T; Yelamali, AR; Arora, J; Aljayyousi, H; Bhatia, M; Haight, AE; Khandelwal, P; Khoury, R; Shah, NC; Stenger, EO; Yelamanchili, N; Shenoy, S. Long-term Follow-up After Mixed Donor Myeloid Chimerism at 1 Year Post Transplantation for Sickle Cell Disease. Transplantation and Cellular Therapy. 2026; 32(6):709.e1-709.e10.

Hahn, T; Zhao, Q; Miller, EG; Elder, P; Langenberg, L; Luebbering, N; Abdullah, S; Neidemire-Colley, L; Holtan, SG; Cataland, SR; Ranganathan, P; Davies, SM; Bejanyan, N; Vasu, S. TA-TMA and GVHD are distinct consequences of endothelial injury: A MIDAS consortium study. Blood advances. 2026.

Haney, M; Pommert, L. Base-Edited Breakthrough: Universal CD7 Chimeric Antigen Receptor T Cells Rewriting the Playbook for Relapsed T-Cell Acute Lymphoblastic Leukemia. The Hematologist. 2026; 23(3).

Hare, K; Hudda, Z; Wassmer, T; Winograd, DR; Klink, G; Myers, K; Childress, K. 16. Incidence of Hepatic Veno-Occlusive Disease Following Hematopoietic Stem Cell Transplant in Patients Treated with Norethindrone Acetate for Menstrual Suppression. Journal of Pediatric and Adolescent Gynecology. 2026; 39(2):356.

Hashimoto, M; Feng, X; Bai, J; Zeng, H; Li, T; Li, J; Umemoto, T; Andreassen, PR; Huang, G. Insights and modulation of RNA polymerase-dependent R-loop and dsRNA in Fanconi anemia hematopoietic stem cells. JCI Insight. 2026; 11(7).

Hayward, H; Engel, E; Hammill, A; Wassmer, T; Breech, L. 164. Vascular Malformations and Gynecologic and Reproductive Health: Results From the Survey of Women with vascular Anomalies (SWAN) Study. Journal of Pediatric and Adolescent Gynecology. 2026; 39(2):322.

Hildenbrand, AK; Lang, A; Hood, AM; Bear, B; Alderfer, MA; Quinn, CT; Crosby, LE. Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease. Pediatric Blood and Cancer. 2026; 73(6):e70292.

Hoeksema, P; Hayatghaibi, S; Sharp, SE; Li, Y; Anton, CG; Norris, RE; Trout, AT. Discrepancies between primary and secondary interpretations of pediatric nuclear medicine imaging examinations. Pediatric Radiology. 2026; 56(2):464-472.

Huber, J; Alkhouli, L; Auletta, JJ; Bakinowski, E; Hunter, L; Bergman, E; Dandoy, CE; Degen, TA; Desalvo, AM; Diaz, J; Parker, L; Schei, T; Stuckey, R; Liang, WH. Operationalizing the CIBMTR Virtual Consortium Program to Advance Collaborative Quality Improvement in Transplant and Cellular Therapy. Transplantation and Cellular Therapy. 2026; 32(2):s562-s563.

Huber, J; Alkhouli, L; Dandoy, CE; Diaz, J; Hunter, L; Kent, G; Liang, WH; Maier, ST; Nguyen, A; Rotz, SJ; Epling, P; Parker, L; Hartley, D. A Multi-Center Self-Service Informatics Platform to Accelerate Quality Improvement in Transplant and Cellular Therapy: The Engraft Registry Power BI Dashboard. Transplantation and Cellular Therapy. 2026; 32(2):s560-s561.

Hudda, Z; Webster, A; Anderson, E; Badia, P; Bagatell, R; Bhar, S; Bidgoli, A; Boyd, K; Chaudhury, S; Cisneros, GS; Weiss, BD; Yazdani, S; Zheng, D; Dandoy, CE. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):199.e1-199.e12.

Ibrahimova, A; Luebbering, N; Strecker, L; Langenberg, L; Abdullah, S; Lake, KE; Wilhelm, J; Lane, A; Gloude, N; Myers, K; Dandoy, C; Towe, C; Khandelwal, P; Jodele, S; Davies, SM. Neutrophil extracellular traps, endothelial injury and use of abatacept for graft versus host disease prophylaxis. Haematologica. 2026.

Ibrahimova, A; Bidgoli, A; Ashraf, A; Krogman, A; Klink, G; Teusink-Cross, A; Schoettler, ML; Davies, SM; Khandelwal, P. Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults. Bone Marrow Transplantation. 2026; 61(4):487-489.

Ibrahimova, A; Badia, P; Davies, SM; Klink, G; Khandelwal, P. α1 – Antitrypsin for Treatment of Acute Graft Versus Host Disease in Children and Young Adults. Transplantation and Cellular Therapy. 2026; 32(2):s270.

Ikegami, S; Pandey, V; Wang, X; Sridharan, A; Mccormack-Spivey, S; Lutzko, CM; Cancelas, JA; Heyenbruch, D; Leemhuis, T; Alquist, CR; Khoury, R; Rubinstein, JD; Davies, S; Grimley, M. LONG-TERM CRYOPRESERVATION PRESERVES THE BIOLOGICAL AND MECHANOBIOLOGICAL ACTIVITY OF THIRD-PARTY VIRUS-SPECIFIC T CELLS. Cytotherapy. 2026; 28(5):102608.

Ivey, N; Zhang, JF; Zack, A; Kakazu, A; Jandarov, R; Kaye, J; Smith, I; Na, J; Koscielski, M; Hagen, M; Wang, K; Plas, DR; Jennifer L, L; A, J. Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review. Surgical Neurology International. 2026; 17:252.

Ivy, CJ; Klink, G; Teusink-Cross, A; Grimley, MS. Evaluating CMV Infection and Reactivation after Emapalumab: A Retrospective Evaluation of Letermovir Prophylaxis. Transplantation and Cellular Therapy. 2026; 32(2):s542.

Iyer, VN; Vethanayagam, D; Al-Samkari, H; Beslow, LA; Chakinala, M; Decker, JE; Faughnan, ME; Galiatsatos, P; Gane, S; Geisthoff, U; White, AJ; Zhou, J; Friday, C; Clancy, M. Letter to the editor. European Archives of Oto-Rhino-Laryngology. 2026; 283(1):599-601.

Jodele, S. Targeting the lectin pathway in TA-TMA. Blood advances. 2026; 10(1):181-182.

Jodele, S; Mizuno, K; Sabulski, A; Dandoy, CE; Ramos, KN; Langenberg, L; Luebbering, N; Webster, A; Klink, G; Mclean, S; Davies, SM. Determinants of Eculizumab Response in High-Risk Transplant-Associated Thrombotic Microangiopathy. Transplantation and Cellular Therapy. 2026; 32(2):s104-s105.

Jose, A; Zacharias, W; Fernandes, S; Yasnogorodsky, M; Elwing, J; Ziady, A. (805) Sotatercept for the Treatment of Portopulmonary Hypertension. The Journal of Heart and Lung Transplantation. 2026; 45(5):375-376.

Jose, A; Zacharias, W; Fernandes, S; Yasnogorodsky, M; Elwing, J; Ziady, A. Sotatercept for the treatment of portopulmonary hypertension: a case report. Communications Medicine. 2026; 6(1).

Josephson, M; Allen, JL; Young, LR; Freedman, J; Towe, C; Koo, J; Myers, K; Woods, JC; Lane, A; Gaffin, JM; Houin, P; Macmillan, M; Davies, SM; Goldfarb, SB. A62-05 Longitudinal Measurement of Respiratory Function by Oscillometry in Children Following Hematopoietic Stem Cell Transplantation (hsct): A Report From the Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2338.

Kapadia, M; Nishitani, M; Alkhouli, L; Badia, P; Blacken, R; Cook, E; Culbertson, C; Dandoy, CE; Daraiseh, N; Davies, SM; Staton, S; Stuckey, R; Young, K; Craddock, J. A Multicenter Quality Improvement Initiative to Reduce Central Venous Catheter Line Days after Transplant Cellular Therapy across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s360-s361.

Kapoor, U; Qayed, MD; Williams, KM; Schoettler, ML; Ibrahimova, A; Khandelwal, P; Krogman, A; Obordo, J; Bidgoli, A. Belumosudil-Induced Reductions in Sirolimus Dosing for Pediatric Chronic GVHD (cGVHD). Transplantation and Cellular Therapy. 2026; 32(2):s602-s603.

Kassim, AA; Thompson, AA; Malik, P. Exploring Affordable Curative Therapy for Sickle Cell Disease in Africa: A Comprehensive Overview. American Journal of Hematology. 2026; 101 Suppl 1(Suppl 1):56-74.

Kazerooni, AF; Jiang, Z; Gandhi, D; Khalili, N; Liu, X; Tu, W; Ware, JB; Familiar, AM; Vunnava, B; Zapaishchykova, A; Resnick, AC; Nabavizadeh, A; Vossough, A; Linguraru, MG. Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas. Radiology: Artificial Intelligence. 2026; 8(3):e250902.

Kelleher, JA; Bernstein, JL; Crisler, KM; Herriott, JK; Klages, KL; Norris, RE; Strenk, ML; Bills, SE; Mcgrady, ME. Patient-Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study. Pediatric Blood and Cancer. 2026; 73(4):e70129.

Kent, G; Alkhouli, L; Dandoy, CE; Davies, SM; Diaz, J; Huber, J; Maier, S; Nguyen, A; O'mathúna, D; Stuckey, R; Rotz, SJ; Parker, L; Juckett, MB. Overcoming Regulatory Barriers: A Case Study of IRB and Dua Navigation in the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s516.

Kent, G; Alkhouli, L; Badia, P; Bakinowski, E; Blevins, C; Dandoy, CE; Davies, SM; Desalvo, AM; Huber, J; Juckett, MB; O'mathúna, D; Parker, L; Spears, K; Pai, AL. Mapping Mental Health Resource Gaps in Transplant Centers: A Multi-Center Comparison of Provider Perception Vs. Actual Availability in the Engraft Learning Network. Transplantation and Cellular Therapy. 2026; 32(2):s366.

Khandelwal, P; Haslam, D; Ibrahimova, A; Laskin, B; Webster, A; Blackard, JT; Lake, K; Hoerth, C; Luebbering, N; Abdullah, S; Davies, SM. The gut virome in children undergoing hematopoietic cell transplantation is diverse and a site for viral reactivation. Bone Marrow Transplantation. 2026.

Khawaja, F; Papanicolaou, GA; Grimley, MS; Gomez, CA; Mahadeo, KM; Elgarten, CW; Marón, GM; Lanier, R; Nielsen-Orzeck, I; Maher, R; Azie, N; Chemaly, RF. Intravenous Brincidofovir Effectively Reduces CMV Dnaemia In Antiviral Experienced Immunocompromised Patients: Results of a Phase 2a Clinical Trial. Transplantation and Cellular Therapy. 2026; 32(3):s19.

Kim, J; Ney, G; Frone, MN; Haley, JS; Ramos, MLF; Mirshahi, UL; Astiazaran-Symonds, E; Shandrina, M; Urban, G; Rao, HS; Ding, Y; Carey, DJ; Gelb, BD; Stewart, DR. Cancer risk in adults with pathogenic germline variants in RAS/MAPK genes using genomic ascertainment. Genetics in Medicine. 2026; 28(6):102561.

Kim, A; Ballman, KV; Wolters, PL; Heise, RS; Shern, JF; Sundby, RT; Lindenberg, L; Lee, M-J; Rastogi, S; Sato, N; Gross, AM; Reinke, D; Cichowski, K; Widemann, BC. SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST). Clinical Cancer Research. 2026; 32(6):1068-1077.

Kirstein, A; Ionascu, D; Lamba, MAS; Ruffolo, BM; Crail, KJ; Mascia, AE; Sertorio, MG; Hinrichs, BH; Zender, C; Lehn, MA; Wise-Draper, TM; Perentesis, JP; Zheng, Y; Wells, SI. In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy. Clinical and Translational Radiation Oncology. 2026; 56:101046.

Klages, KL; Herriott, JK; Breen, G; Norris, RE; Beal, SJ; Sorge, CE; Pai, ALH; Mcgrady, ME. Pain, Internalizing Symptoms, Posttraumatic Stress, and Alcohol Use Among Young Adult Survivors of Cancer. Pediatric Blood and Cancer. 2026; 73(4):e70154.

Klink, G; Mizuno, K; Teusink, A; Mclean, S; Davies, SM; Jodele, S. A Decade of Precision: PK/PD-Guided Eculizumab Therapy for TA-TMA Management. Transplantation and Cellular Therapy. 2026; 32(2):s615.

Koo, J; Webster, A; Lake, KE; Luebbering, N; Dandoy, C; Jodele, S; Ryan, TD; Davies, SM; Sabulski, A. Proteomic analysis of pericardial effusions in hematopoietic stem cell transplant recipients. Haematologica. 2026; 111(4):1484-1489.

Koo, J; Langenberg, L; Zhao, X; Setchell, KR; Lake, KE; Luebbering, N; Walter, E; Lane, A; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lipid dysregulation after hematopoietic stem cell transplant. Haematologica. 2026; 111(5):1634-1645.

Koo, J; Miller, E; O'conner, A; Myers, KC; Mehta, PA; Davies, SM. Radiation-Free Reduced-Intensity Conditioning Achieves Excellent Outcomes in Pediatric Severe Aplastic Anemia. Transplantation and Cellular Therapy. 2026; 32(2):s581.

Koo, J; Langenberg, L; Walter, E; Zhao, X; Setchell, K; Lake, KE; Khandelwal, P; Lane, A; Manjrekar, P; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lower Isn't Better: Baseline LDL-C Identifies Endothelial Vulnerability and Outcomes after HSCT. Elsevier; 2026:s594.

Koo, J; Schwarz, D; Haney, M; Putra, J; Kim, J; Cheng, L; Korn, E; Steltz, S; Schwarz, L; Loveless, S; Myers, KC; Shimamura, A; Grover, AS; Wehrman, A. Liver disease in Shwachman-Diamond syndrome: A comprehensive characterization across the age spectrum. Journal of Pediatric Gastroenterology and Nutrition. 2026; 82(6):1357-1365.

Kotch, C; Perreault, S; Power, P; Adams, DJ; Aldape, K; Avery, RA; Bandopadhayay, P; Capper, D; De Blank, P; Entz-Werle, N; Zhu, Y; Fisher, MJ; Hargrave, D; Kilburn, LB. Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade Glioma. Neuro-Oncology. 2026.

Kotch, C; De Blank, P; Fangusaro, J; Fisher, MJ. MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. Neuro-Oncology Advances. 2026; 8(Suppl 2):ii14-ii24.

Kotch, C; Avery, RA; Franson, AT; Hargrave, D; Brossier, NM; Bornhorst, M; Rangnath, S; Nevel, KS; Robison, NJ; Liu, GT; Fisher, MJ; De Blank, P. Clinical safety and efficacy of bevacizumab in combination with mitogen-activated protein kinase kinase inhibitor therapy for glioma: a retrospective analysis. Neuro-Oncology Pediatrics. 2026; 2(1).

Langenberg, L; Ibrahimova, A; Jodele, S; Holtan, S; French, K; Davies, SM; Khandelwal, P. Serum Amphiregulin Differentiates Acute GI GVHD from Infectious Colitis. Transplantation and Cellular Therapy. 2026; 32(2):s248.

Lanzkron, S; Coleman-Cowger, VH; Thompson, AA; Carroll, CP; Clemons, T; Debaun, M; Kanter, J; Malik, P; Manwani, D; Pierciey, FJ; Walters, MC; Alai, S. Cure Sickle Cell Initiative recommendations on common data elements for sickle cell disease gene therapy trials. Blood advances. 2026; 10(11):3960-3965.

Latham, TS; Kiyaga, C; Hernandez, AG; Nakafeero, M; Kadde, N; Stuber, SE; Ndeezi, G; Aceng, JR; Ware, RE. High early mortality among Ugandan children with sickle cell anemia and congenital HIV identified by newborn screening. Blood Global Hematology. 2026; 2(2):100093.

Lawhorn, E; Mani, B; Howell, JC; Davies, SM; Myers, K; Hudda, Z. Longitudinal Outcomes of Reproductive Function in Male Pediatric Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy. 2026; 32(2):s356.

Lee, YS; Good, JD; Awais, N; Eschle, BK; Lineberry, MS; Lin, J; Wunderlich, M; Thibodeau, J; Edwards, H; Teo, JL; Garcia, JS; Lane, AA; Jones, CL; Van Galen, P. Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia. Blood Neoplasia. 2026; 3(2):100202.

Lee, D; Abu-Shihab, Y; Plas, K; Nicolet, D; Mrózek, K; Routbort, MJ; Patel, KP; Walker, CJ; Buss, J; Stiff, AR; Tyner, JW; Loghavi, S; Eisfeld, A-K; Miles, LA. Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia. Leukemia. 2026.

Levine, AB; Bennett, J; Patil, P; Burns, I; Siddaway, R; Li, C; Haizel-Cobbina, J; Rana, M; Yuditskiy, R; Son, A; Rutka, JT; Dewan, MC; Tabori, U; Hawkins, CE. Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2026; 28(2):535-551.

Li, J; Merkel, E; Grier, D; Zimmermann, N; Hodjat, P; Sabharwal, S; Breese, EH; Lorsbach, RB. Maternal-Fetal Transmission of Diffuse Large B-Cell Lymphoma. Pediatric Blood and Cancer. 2026; 73(2):e32174.

Li, X; Aguilar-Navarro, AG; Nader, M; Jahangiri, S; Lee, HS; Edun, G; Gower, M; Yang, D; Fernandez, M; Lin, B; Kim, Y-M; Adams, RH; Sivaraj, KK; Tikhonova, AN. IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy. Blood. 2026.

Liberio, N; Allbee-Johnson, M; Ahn, KW; Moskop, A; Phelan, R; Shaw, BE; Page, KM; Schultz, KR; Phillips, CL; Mehta, PA; Kapoor, N; Doherty, EE; Chavan, RS; Broglie, L. Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. Journal of Clinical Oncology. 2026; 44(11):1003-1015.

Ling, T; O'brien, C; St-Germain, JR; Rondeau, V; Shi, M; Berman, JM; Cepa, A; Saez Raez, P; Wunderlich, M; Carter, KM; Hope, KJ; D'alessandro, A; Raught, B; Jones, CL. Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. Blood. 2026; 147(8):863-876.

Luebbering, N; Abdullah, S; Webster, A; Mccormack-Spivey, S; Koo, J; Jodele, S; Davies, SM; Sabulski, A. Pre-Transplant Inflammation Promotes Endothelial to Mesenchymal Transition in Pediatric TA-TMA. Transplantation and Cellular Therapy. 2026; 32(2):s604-s605.

Maier, ST; Dandoy, CE; Davies, SM; Gorfinkel, L; Huber, J; Jodele, S; Kapadia, M; Kent, G; Lehmann, LE; Myers, K; Nguyen, A; Nishitani, M; Parker, L; Epling, P. Activating Epic’s Flowsheet for Standardized Chronic GVHD Assessment: A Multi-Center Implementation Framework to Enable Standardized Documentation. Transplantation and Cellular Therapy. 2026; 32(2):s520-s521.

Manjrekar, P; Lies, E; Davies, SM; Laskin, B; Jodele, S; Sabulski, A. Kidney Injury Markers in Pediatric TA-TMA: In the World of Serum Creatinine, be a Cystatin C or Urine Protein. Transplantation and Cellular Therapy. 2026; 32(2):s588-s589.

Margol, AS; Hoffman, LM; Ronsley, R; Tran, J; Malvar, J; Chi, Y-Y; Leary, S; Stevens, J; Faulk, KE; Salloum, R; Gilheeney, S; Szalontay, L; Reddy, AT; Dhall, G. A multi-institutional report of children with atypical teratoid rhabdoid tumor treated with intensive multimodal therapy. Neuro-Oncology Practice. 2026; npag014.

Marsh, RA; Cowan, MJ. The evolving landscape of primary hemophagocytic lymphohistiocytosis: Long-term outcomes following hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology. 2026; 157(2):340-341.

Marshall, MK; Tolani, D; Bender, JD; Lamour, JM; Bansal, N. Heart transplantation in pediatric oncology patients. JHLT Open. 2026; 12:100514.

Mccormack-Spivey, S; Wilhelm, J; Ikegami, S; Rubinstein, JD; Hudda, Z; Khoury, R; Davies, SM; Grimley, MS. Duration of Cryopreservation of Third-Party Viral Specific T-Cells (TP-VSTs) Does Not Influence Clinical Efficacy. Transplantation and Cellular Therapy. 2026; 32(2):s131.

Mccormack-Spivey, S; Walter, E; Langenberg, L; Jodele, S; Davies, SM; Sabulski, A. Serine Proteinase Inhibitor (Serpin) E1 As an Early Urine Biomarker of Subclinical Renal Fibrosis in Children with Transplant Associated Thrombotic Microangiopathy (TA-TMA) Transplantation and Cellular Therapy. 2026; 32(2):s589.

Mcgrady, ME; Ketterl, TG; Webster, RT; Burns, MMK; Bills, SE; Burke, M; Szulczewski, L; Brock, MY; Schwartz, LE; Herriott, JK; Hommel, KA; Pai, ALH; Mara, CA; Norris, RE. Feasibility Trial of a Tailored Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer. Pediatric Blood and Cancer. 2026; 73(1):e32127.

Mckenney, KD; Kalb, LG; Hammill, AM; Comi, AM. Development and Retrospective Application of Novel Outcome Measure: Sturge–Weber Syndrome Acute Crisis (SWAC) Index. Annals of the Child Neurology Society. 2026.

Mcnerney, KO; Kwon, S; Naik, S; Fabrizio, VA; Llaurador, G; Sanchez-Pinto, LN; Talleur, AC; Zeng, XL; Baggott, C; Vatsayan, A; Mackall, CL; Laetsch, TW; Gardner, RA; Schultz, L. Validation of a Pre-Infusion Prediction Model for IEC-HS in Children and Young Adults with B-Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 2026; 32(2):s580.

Mehta, RS; Wang, T; Pidala, JA; Huffman, C; Farhadfar, N; Defilipp, Z; Khandelwal, P; Spellman, SR; Lee, SJ; Jurdi, NE; Bejanyan, N. Calcineurin Inhibitor Versus Sirolimus As Immunosuppressive Partners with Ptcy-Based GVHD Prophylaxis in Adults Undergoing Hematopoietic Cell Transplantation for Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2026; 32(2):s264-s265.

Mejía-Ramírez, E; Picazo, PI; Walter, B; Montserrat-Vazquez, S; Affuso, F; Wieser, S; Pezzano, F; Reymond, L; Castillo-Robles, J; Matteini, F; Ruprecht, V; Zheng, Y; Petrone, P; Florian, MC. Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells. Nature Aging. 2026; 6(1):68-87.

Mishra, AK; Langenberg, L; Strecker, L; Zhao, Q; Jodele, S; Sabulski, A; Vasu, S; Bejanyan, N; Hahn, TE; Davies, SM. Transplant Associated Thrombotic Microangiopathy (TA-TMA) Is Mechanistically Different in Adults and Children- a MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium Study. Transplantation and Cellular Therapy. 2026; 32(2):s69.

Morales Junior, R; Hambrick, HR; Benoit, SW; Klink, G; Mizuno, T; Tang Girdwood, S. Population pharmacokinetics and Monte Carlo simulation of Cefepime in paediatric and Young adult bone marrow transplant patients. British Journal of Clinical Pharmacology. 2026.

Morrison, A; Myers, K; Streich-Tilles, T. Human papillomavirus vaccine uptake among adolescent survivors of hematopoietic stem cell transplant. Journal of Cancer Survivorship. 2026; 20(3):1046-1054.

Munidasa, SR; Koo, J; Cooper, R; Hils, B; Edwards, SL; Myers, KC; Abts, MF; Lake, KE; Baker, SK; Doherty, EE; Goldfarb, S; Davies, SM; Deterding, RR; Woods, JC. B17-08 CT Predicts Lung-Related Events in Children Post-Hematopoietic Stem Cell Transplant: A TRANSPIRE Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.6570.

Munshi, PN; Yuen, C; Al-Juhaishi, T; Jensen, E; Nemecek, ER; Sandmaier, BM; Davies, SM; Auletta, JJ; Chakrabarty, JH. Breaking Access Barriers to Autologous Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy in Hematologic Malignancies-an ASTCT-NMDP ACCESS Initiative. Transplantation and Cellular Therapy. 2026; 32(6):737-753.

Muruato, L; Towe, C; Myers, K. C60-05 The Utility of Bronchoscopy Prior to Bone Marrow Transplant in Children: A Retrospective Case Series. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.3527.

Myers, KC; Skala, EJ; Ghandikota, S; Jegga, AG; Mousa, N; Siefert, ME; Lane, A; Reffatto, V; Towe, C; Luebbering, N; Bridgeland, A; Goldfarb, S; Davies, SM; Ziady, AG. Blood proteomics of paediatric bronchiolitis obliterans syndrome after haematopoietic cell transplant. ERJ Open Research. 2026; 12(3).

Nalapareddy, K; Haslam, DB; Kissmann, A-K; Alenghat, T; Stahl, S; Rosenau, F; Zheng, Y; Geiger, H. Microbiota from young mice restore the function of aged ISCs. Stem Cell Reports. 2026; 21(2):102788.

Namazzi, R; Opoka, RO; Ssuuna, C; Goings, MJ; Mcelhinney, K; Datta, D; Ware, RE; John, CC; Conroy, AL. Hydroxyurea interferes with point-of-care creatinine testing in children with sickle cell anemia. BMC Research Notes. 2026.

Nelson, AS; Pence, L; Khandelwal, P; Jodele, S; Davies, SM; Huber, J; Benoit, SW. Endothelial Protection Reduces PRES in Pediatric Allogeneic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2026; 32(2):s609.

Nisarga, P; Rathore, B; Hodjat, P; Derinkuyu, BE; Graham, RT; Skoch, J; Leino, D; Gupta, K. Diagnostic pitfall: BCOR immunoreactivity in a molecularly confirmed astroblastoma, MN1-altered (HGNET-MN1). Clinical Neuropathology. 2026; 45(1):32-35.

Novitzky-Basso, I; Xu, C; Chiarello, C; Reisz, JA; D'alessandro, A; Bader, GD; Mattsson, J; Jones, C. Metabolomic Signatures of Relapse and Survival in AML Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Hematology Reports. 2026; 18(2).

Ntoumaziou, A; Risinger, M; Elgammal, Y; Zhang, W; Kalfa, TA; Smart, LR. Cryohydrocytosis: When Cold Breaks the Membrane. American Journal of Hematology. 2026; 101(6):1217-1219.

Obermark, T; Debnath, P; Ayyala, RS; Danziger-Isakov, LA; Koo, J; Myers, KC; Otto, WR; Tanimoto, A; Trout, AT; Morin, CE. Utility of Computed Tomography Surveillance of Asymptomatic Infection in Children and Young Adults Before Allogeneic Hematopoietic Stem Cell Transplant. Pediatric Blood and Cancer. 2026; 73(5):e70175.

Orange, JS; Chinen, J; Horner, CC; Kobrynski, LJ; Ballow, M; Butte, MJ; Chandrakasan, S; Chinn, IK; Satter, LF; Freeman, AF; Greenhawt, M; Ledford, DK; Mosnaim, G; Wang, J. 2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS). Annals of Allergy, Asthma and Immunology. 2026; 136(4):426-493.e1.

Orduña, P; Cansanay, RD; Erker, C; Ratterman, E; Schlosser, MP; Ronsley, R; Cacciotti, C; Cheng, S; Hukin, J; Aguilera, D; Rutkowski, S; Lassaletta, A; Bouffet, E; Lafay-Cousin, L. Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach. Pediatric Blood and Cancer. 2026; 73(5):e70181.

Otto, W; Rickerman, L; Leon, MD; Huang, FS; Sankaranarayanan, K; Dandoy, C; Lamson, DM; Kajon, AE. A Pediatric Case of Rapidly Progressing Disseminated Human Adenovirus C1 Infection with Multiorgan Failure and Evidence of Intra-Host Variation. Viruses. 2026; 18(6):607.

Pence, L; Huber, J; Jodele, S; Davies, SM; Benoit, SW. Posterior Reversible Encephalopathy Syndrome in a Pediatric Hematopoietic Stem Cell Transplant Cohort: Characteristics and Associated Complications. Transplantation and Cellular Therapy. 2026; 32(2):s600.

Peters, EJ; Gardner, KL; Privette Vinnedge, LM. All hands on DEK: structural insights into a unique histone modifier and chromatin remodeler. Epigenetics and Chromatin. 2026; 19(1).

Pommert, L. First, Do No Transplant? Emerging Evidence for Watchful Waiting in Select Juvenile Myelomonocytic Leukemia Patients. The Hematologist. 2026; 23(2).

Pommert, L; Tasian, SK. No Data Zone Hope on Hold: Novel Drug Access Out of Reach for Children With Acute Myeloid Leukemia Despite Adult Successes. The Hematologist. 2026; 23(1).

Power-Hays, A; Quinn, CT. Liquid Hydroxyurea (Xromi) for Children With Sickle Cell Anemia: A New Solution Compounding Existing Problems. Pediatric Blood and Cancer. 2026; 73(3):e70143.

Power-Hays, A; Mcelhinney, KE; Williams, TN; Mochamah, G; Olupot-Olupot, P; Paasi, G; Reid, ME; Rankine-Mullings, AE; Opoka, RO; John, CC; Stuber, SE; Latham, TS; Vinks, AA; Ware, RE. Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations. Blood advances. 2026; 10(2):418-427.

Quinn, CT. More disease-modifying therapies for sickle cell disease: Are small molecules and drug repurposing the way forward? Seminars in Hematology. 2026.

Quinn, CT. Intrinsic Hemolytic Anemias: Non-hemoglobinopathies. In: Classical Hematology. Springer Nature; 2026:65-78.

Rai, P; Roy, S; Arumugam, P; Konstantinidis, DG; Ponny, SR; Eiymo Mwa Mpollo, M-S; Shrestha, A; Kalfa, TA; Malik, P. Angiotensin signaling is essential for stress erythropoiesis but causes retention of dysfunctional mitochondria in RBCs. JCI Insight. 2026; 11(9).

Ramos, KN; Langenberg, L; Lake, KE; Hoerth, C; Luebbering, N; Haslam, D; Newburg, D; Morrow, AL; Ollberding, NJ; Teusink, A; Watanabe-Chailland, M; Romick-Rosendale, L; Davies, SM; Khandelwal, P. 2’-Fucosyllactose (Human Milk Oligosaccharide) Reduces Dysbiosis and Acute GI GVHD in Children and Young Adults Following HSCT: A Prospective, Single-Center Phase II Study. Transplantation and Cellular Therapy. 2026; 32(2):s570.

Rangarajan, HG; Stenger, EO; Shenkar, R; Stanek, J; Alzaharani, M; Hsieh, M; Limerick, E; Darrigo, LG; Bonfim, C; Bhatia, M; Horan, J; Guilcher, GM; Kassim, AA; Abraham, A. Outcomes Following Graft Failure and Second Subsequent Allogeneic Hematopoietic Cell Transplant in Patients with Sickle Cell Disease: A Multicenter Study. Transplantation and Cellular Therapy. 2026; 32(2):s18-s19.

Rangarajan, HG; Chellapandian, D; Atshan, R; Ahn, KW; Kumar, S; Knight, TE; Leung, W; Ganguly, S; Williams, KM; Shah, NN; Qayed, M; Sharma, A; Broglie, L; Satwani, P. Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report. Transplantation and Cellular Therapy. 2026; 32(5):580.e1-580.e18.

Raskin, S; Yang, C; Lin, T; Yearley, J; Blumenschein, W; Pillay-Smiley, N; Lenzen, A; Partap, S; Fangusaro, J; Gururangan, S; Onar-Thomas, A; Fouladi, M; Dunkel, I; Mitchell, DA; Hwang, EI. An analysis of PD1 pathway activity in malignant pediatric central nervous system tumors: a pediatric brain tumor consortium study, PBTC-N13. Neuro-Oncology Pediatrics. 2026; 2(2):wuag020.

Raut, NGR; Sprague, KL; Adlakha, A; Rupert, AR; Hofmann, MC; Queme, LF; Ratner, N; Jankowski, MP. MAPK-dependent release of GDNF from Schwann cells mediates tumor-independent pain in neurofibromatosis 1. Science Signaling. 2026; 19(939):eaee5174.

Ravindran, R; Kedei, N; Youn, E-K; Choi, K; Volz, A; Pundavela, J; Largaespada, DA; Shern, JF; Ratner, N. Abstract 2269: Two-step mechanism of plexiform neurofibroma formation: Role of the NF-κB pathway in neurofibroma formation. Cancer Research. 2026; 86(7_Supplement):2269-2269.

Rayes, A; Logan, BR; Liu, X; Dara, J; Buckley, RH; Oved, JH; Kapoor, N; Kapadia, M; Chandra, S; Martinez, CA; Heimall, J; Haddad, E; Pai, S-Y; Dvorak, CC. Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC. Blood advances. 2026; 10(3):887-900.

Reel, SM; Roy, S; Leino, D; Gatts, J; Raskin, S. The first described report of a patient with CHD7-associated CHARGE syndrome and a spinal schwannoma with a SH3PXD2A::HTRA1 fusion; a case report and review of literature. Neuro-Oncology Pediatrics. 2026; 2(2):wuag034.

Reel, SM; Raskin, S. Overview of the neurotrophic tyrosine receptor kinase signaling pathway and therapeutic applications to brain tumors. In: Handbook of Brain Tumor Chemotherapy Molecular Therapeutics and Immunotherapy. 2026:501-513.

Reel, SM; Raskin, S. Chapter 29 Overview of the neurotrophic tyrosine receptor kinase signaling pathway and therapeutic applications to brain tumors. In: Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Elsevier; 2026:501-513.

Ren, L; Zhang, H; Bobileva, O; Nai, F; Bi, H; Chan, A; Baker, GE; Dong, L; Guarin, D; Hu, W; Chen, J; Caflisch, A; Li, X; Su, R. Targeting the METTL1/m7G axis as a therapeutic strategy in myeloid leukemia. Blood. 2026; 147(25):3069-3085.

Rineer, S; Mcgann, PT; Paschal, C; Ambrose, EE; Smart, L. Validation of a Swahili Pediatric Pain Scale in Tanzania: An Observational Study. Pain Management Nursing. 2026.

Rollins, AL; Rujumba, J; Namazzi, R; Munube, D; John, CC; Ware, RE; Apolot, D; Ssali, A; Henry, N; Opoka, RO. The role of outer setting health system factors in the use of hydroxyurea for Ugandan children with sickle cell anemia. Blood Global Hematology. 2026; 2(2):100091.

Roome, RB; Yadav, A; Flores, L; Puarr, AK; Nardini, D; Richardson, A; Waclaw, RR; Arkell, RM; Menon, V; Johnson, JE; Levine, AJ. Ontogeny of the spinal cord dorsal horn. Science. 2026; 391(6781):eadx5781.

Sabulski, A; Webster, A; Langenberg, L; Luebbering, N; Myers, KC; Dandoy, CE; Libermann, TA; Dillon, ST; Gu, X; Clark, DM; Snyder, AJ; Jodele, S; Davies, SM. Plasma proteomics and single-cell RNA-seq identify cellular and soluble mechanisms of graft rejection after HSCT. Blood Immunology & Cellular Therapy. 2026; 2(2):100046.

Sabulski, A; Webster, A; Mizuno, K; Luebbering, N; Davies, SM; Jodele, S. Multiomics Reveal Interferon-Induced Cell Senescence As a Novel Mechanism of Eculizumab Resistance in TA-TMA. Transplantation and Cellular Therapy. 2026; 32(2):s594-s595.

Sabulski, A; Mccormack-Spivey, S; Webster, A; Strecker, L; Laskin, B; Blackard, JT; Walder, T; Hurst, T; Seif, AE; Jodele, S; Davies, SM. A Multiomic Study Reveals Pilra, Monocytes and Interferons Put the “Itis” in BK Polyomavirus Cystitis. Transplantation and Cellular Therapy. 2026; 32(2):s95.

Sachs, CM; Gross, AM; Widemann, BC; Shern, JF; Sundby, RT. Abstract 2548: Circulating proteomic signatures for subtyping NF1 associated peripheral nerve sheath tumors. Cancer Research. 2026; 86(7_Supplement):2548-2548.

Sagar, K; Boscolo, E. Advances in genetics, signaling, and modeling of venous malformations. Frontiers in Cardiovascular Medicine. 2026; 13:1770126.

Schuemann, J; Rothwell, B; Mascia, A; Fan, Y; Loo, BW; Yock, T; Liu, KX; Perentesis, J; Haas-Kogan, DA. The potential and risks of FLASH radiotherapy in pediatric patients. Adaptation. 2026; 2(1):wuaf014.

Shahid, S; Mauguen, A; Mcavoy, D; Hosszu, K; Phillips, CL; Schultz, L; Hsieh, EM; Bonifant, CL; Fabrizio, VA; Bisogno, B; Pena, MP; Chapman, N; Boelens, J; Curran, KJ. Phase II One Arm Multicenter Study of Early Reinfusion of Tisagenlecleucel to Promote Durable B-cell Aplasia in Pediatric and Young Adult Patients with relapsed/refractory CD19-Positive B-cell Acute Lymphoblastic Leukemia (REFUEL) Transplantation and Cellular Therapy. 2026; 32(2):s593-s594.

Shook, LM; Ware, RE. Advances and Gaps in Global Newborn Screening for Sickle Cell Disease. International Journal of Neonatal Screening. 2026; 12(1).

Sil, S; Mooney, JT; Adkins, TR; Sinha, C; Nunez, MA; Busbee, A; Dampier, CD; Bai, S; Crosby, LE; Thomas, S; Myer, GD; Bakshi, N; Kesar, T; Kashikar-Zuck, S. I-STRONG: An integrative, multicomponent treatment approach for chronic pain in pediatric sickle cell disease. Blood advances. 2026.

Smart, LR; Segbefia, CI; Odame, I. Creative and Adaptive Solutions for Early Diagnosis of Sickle Cell Disease in Sub-Saharan Africa. American Journal of Hematology. 2026; 101 Suppl 1(Suppl 1):17-32.

Smiley, NP; Lane, A; Webster, A; Blank, C; Hawkins, C; Hassall, T; Leach, J; Dorris, K; Jones, B; Hansford, JR; Zaghloul, M; Cheng, S; Hummel, TR; Hoffman, LM; Warren, KE. Re-irradiation practices and outcomes in patients with diffuse intrinsic pontine glioma (DIPG): A report from the International DIPG/DMG Registry. Neuro-Oncology Pediatrics. 2026; 2(2):wuag013.

Spears, K; Alkhouli, L; Badia, P; Cook, E; Dandoy, CE; Davies, SM; Huber, J; Kapadia, M; Kent, G; Klinger, J; Parker, L; Snyder, AJ; Staton, S; Maier, S. Quantifying the Cost and Practice Variation of Central Venous Catheter Maintenance across the Engraft Learning Health Network. Transplantation and Cellular Therapy. 2026; 32(2):s475-s476.

Steinway, C; Carbaugh, L; Belton, T; Teng, O; Shults, J; Bennett, L; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Andemariam, B; Rubin, D; Smith-Whitley, K; Jan, S. Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study. Pediatric Blood and Cancer. 2026; 73(6):e70252.

Strecker, L; Abts, MF; Freedman, J; Baker, K; Doherty, E; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, M; Young, LR; Zinter, M; Davies, SM; Ibrahimova, A. C74-09 MCP-1 in Broncho-Alveolar Fluid and Plasma in Children With Lung Injury After Hematopoietic Stem Cell Transplant: A Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.5449.

Strecker, L; Mishra, A; Abts, MF; Freedman, J; Baker, K; Doherty, E; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Young, LR; Zinter, M; Davies, SM; Ibrahimova, A. B101-02 To Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.5393.

Strecker, L; Abts, MF; Baker, KS; Freedman, JL; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Josephson, MB; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. MCP-1 in Broncho-Alveolar Fluid and Plasma in Children with Lung Injury after Hematopoietic Stem Cell Transplant: A Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s581-s582.

Strecker, L; Mishra, AK; Abts, MF; Freedman, JL; Baker, S; Doherty, EE; Eissa, H; Gaffin, JM; Goldfarb, SB; Houin, P; Young, LR; Zinter, MS; Davies, SM; Ibrahimova, A. “to Bronch or Not to Bronch? - Biologic Markers of Lung Injury in the Bronchoalveolar Lavage Fluid of Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation, a Transpire Study. Transplantation and Cellular Therapy. 2026; 32(2):s584-s585.

Taggart, CB; Bota, KE; Ramos, KN; Dandoy, CE; Davies, SM. From Standard Formulas to Individualize Care: Optimizing HSCT Nutrition through Metabolic Cart Assessments. Transplantation and Cellular Therapy. 2026; 32(2):s595-s596.

Tang, W; Li, Y; Boscolo, E; Kohane, DS; Cullion, K. Polymeric rapamycin nanoparticles encapsulating ponatinib cause regression of venous malformations in mice. Science Translational Medicine. 2026; 18(848):eaeb7597.

Taylor, AO; Hong, S; Jones, S; Ng, K; Gooley, TA; Bhatt, N; Hellewell, EM; Sung, AD; Ahmed, N; Morey, C; Yingling, S; Edgar, CM; Browning, AL; Lee, CJ. Relationship between Social Drivers of Health and Clinician Adherence to Late Effects Screening Among Allogeneic HCT Survivors in the United States. Transplantation and Cellular Therapy. 2026; 32(2):s24-s25.

Thant, MM; Gollamudi, J; Benoit, SW; Chonat, S; Cancelas, JA. Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course. British Journal of Haematology. 2026; 208(6):2311-2314.

Uible, EE; Choi, I; Clough, CA; Hassan, A; Anandappa, AJ; Fisher, J; Karki, B; Hueneman, K; Choi, K; Vick, EJ; Pasare, C; Cunningham, JT; Volk, AG; Starczynowski, DT. Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemia. Cell Chemical Biology. 2026; 33(1):59-73.e10.

Urrego, F; Josephson, M; Allen, JL; Young, LR; Towe, C; Koo, J; Myers, K; Woods, JC; Lane, A; Gaffin, JM; Robinson, PD; Houin, P; Davies, SM; Goldfarb, SB. A62-04 Comparison of Home Spirometry to Office Spirometry in Children and Young Adults Post Hematopoietic Stem Cell Transplant in the Transpire Research Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2957.

Verkamp, B; Jordan, MB; Allen, CE. Pediatric hemophagocytic lymphohistiocytosis: current conceptualization, diagnosis, and treatment. Blood. 2026; 147(10):1019-1036.

Verkamp, B; Bota, KE; Taggart, CB; Ashraf, A; Klink, G; Langenberg, L; Jodele, S; Davies, SM; Khandelwal, P. C You Later, Endothelial Injury! Low Vitamin C Post-Hematopoietic Cell Transplant Predisposes to Endothelial Injury and Overall Mortality in Children. Transplantation and Cellular Therapy. 2026; 32(2):s586-s587.

Vichare, V; Kilich, G; Cunningham-Rundles, C; Onyekaba, M; Abraham, RS; Puck, J; Fuleihan, R; Marsh, RA; Sullivan, KE. Automated data extraction model for the USIDNET registry: Bigger, faster, and better data collection. Journal of Human Immunity. 2026; 2(1):e20250118.

Vucianis, T; Foster, KE; Nakamura, A; Hossain, M; Gover, I; Diebold, S; Towe, C; Ruff, K; Burg, G; Hardie, WD; Myers, K; Hayes, D; Paisley, A. A99-07 Benefits of Pulmonary Rehabilitation for Pediatric Chronic Respiratory Disease. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.6106.

Walder, TA; Hillenbrand, CA; Hirsch, HH; Starrett, GJ; Sabulski, A; Buck, CB; Justice, J; Laskin, BL; Davies, SM; Blackard, JT. Insight Into Current BK Polyomavirus Research Efforts: BK Day Meeting 2024. Transplantation. 2026; 110(5):e948-e951.

Ware, RE. Sickle Cell Disease in Sub-Saharan Africa: Progress and Potential. American Journal of Hematology. 2026; 101 Suppl 1:3-4.

Ware, RE; Opoka, RO; Latham, T; Kasirye, P; Kasembo, P; Hume, H; Birungi, I; Kadde, N; Wambaka, B; Nakafeero, M; Conroy, AL; Tomlinson, G; Lane, A; John, C. Ten Years of Hydroxyurea for Ugandan Children with Sickle Cell Anemia. New England Journal of Medicine. 2026; 394(20):2059-2061.

Warner, MA; Hanson, AC; Johnson, ML; Go, RS; Gajic, O; Schulte, PJ; Kor, DJ; Serra, M; Kalfa, TA; Blanc, L. Longitudinal changes in haemoglobin, iron stores, and inflammatory markers following surgery and in critical illness: an analysis from the Practical Anaemia Bundle for Sustained Blood Recovery randomised clinical trial. British Journal of Anaesthesia. 2026; 136(2):516-524.

Weldengus, TM; Liu, B; Kou, F; Lyu, Y; Chen, J; Fan, Q; Zou, C. InstantRetouch: Personalized Image Retouching without Test-time Fine-tuning Using an Asymmetric Auto-Encoder. . 2026; abs/2602.17044.

Widemann, BC; Gross, AM; Dombi, E; Sankaran, H; Shern, JF. Evolution of Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1: Opportunities for Prevention and Therapeutic Strategies. Annual Review of Cancer Biology. 2026; 10(1):223-241.

Williams, KB; Larsson, AT; Keller, BJ; Chaney, KE; Williams, RL; Bhunia, MM; Draper, GM; Jubenville, TA; Hudson, WA; Georg, GI; Moertel, CL; Ratner, N; Largaespada, DA. Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors. Molecular Cancer Therapeutics. 2026; 25(2):230-243.

Wong, W; Josephson, M; Allen, JL; Young, LR; Abts, MF; Houin, P; Deterding, RR; Urrego, F; Carmona, MDS; Towe, C; Macmillian, M; Eissa, H; Cisneros, GS; Goldfarb, SB. A62-07 Transpire: Acute Worsening in DLCO Followed by Rebounding Longitudinal Improvement After Pediatric Hematopoietic Stem Cell Transplant in a Multicenter Study. American Journal of Respiratory and Critical Care Medicine. 2026; 212(Supplement_1):aamag162.2339.

Wright, E; Billups, C; Rush, S; Li, Y; Janns, A; Michalski, JM; Salloum, R; De Blank, P. Cumulative dose of chemotherapy and survival outcomes in children with average risk medulloblastoma treated on Children's Oncology Group study ACNS0331. Neuro-Oncology. 2026.

Wudhikarn, K; Gowda, L; Ye, Q; Oloyede, T; Martens, M; Banerjee, R; Devarakonda, SS; Liu, H; Herr, MM; Young, J-AH; Akhtar, OS; Auletta, JJ; Huppler, AR; Abid, MB. Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2026.

Xing, Y; Yang, Y; Hong, Z; Tian, C; Chu, H; Prokop, SC; Cai, H; Gu, M; Tchieu, J; Mackie, K; Guo, F. Organoid Brain-Machine-Interface Devices for Central Nervous System Repair. Advanced Science. 2026; e75444.

Yang, Y; Liu, X; Wei, J; Qin, J; Tan, Q; Ji, J; Guo, F; Zheng, Y; Bi, F; Liu, M; Wang, G. In vivo expression of CD3/CD19 bispecific T-cell engager and α-PD-L1-Fc enables effective and durable immunotherapy for CD19+/PD-L1+ leukemia. Leukemia. 2026; 40(2):348-359.

Yue, M; Wang, Y; Gu, J; Zhang, C; Chen, Y; Gao, A; Choi, K; Wu, Z; Wang, Z; Pundavela, J; Ratner, N; Yu, Y. Decreased PP2A expression and activity represent a therapeutic target for plexiform neurofibroma. Acta Neuropathologica Communications. 2026.

Zhang, X; Xue, J; Zhao, C; Zeng, C; Zhong, J; Yu, G; Yang, X; Ling, Y; Li, D; Yang, J; Lu, QR; Deng, Y; Tang, Z; Lu, F. Oligodendrocyte transcription factor 2 orchestrates glioblastoma immune evasion by suppressing CXCL10 and CD8+ T cell activation. Journal of Clinical Investigation. 2026; 136(5).

Zhang, Z; Fan, C; Jorgensen, R; Sylvestre, P; Adam, M; Zheng, Y. Loss of polarity by Cdc42 depletion and oncogenic Kras activation in the mouse intestinal epithelia leads to a necrotizing enterocolitis (NEC)-like disease. Nature Communications. 2026; 17(1).

Zhang, W; Todd, KE; Dawson, DB; Luchtman-Jones, L; Palumbo, JS. Molecular diagnosis of inherited platelet disorder via a targeted whole-exome virtual gene panel: a 5-year institutional experience. Research and Practice in Thrombosis and Haemostasis. 2026; 10(2):103413.

Zhou, Z; Wang, T; Mccurdy, SR; Nath, R; Huffman, C; Farhadfar, N; Defilipp, Z; Khandelwal, P; Spellman, SR; Jurdi, NE; Lee, SJ; Munshi, PN. Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor and Methotrexate GVHD Prophylaxis, with or without ATG, in HLA-Matched Related and Unrelated Donor Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies Undergoing Reduced-Intensity Conditioning: A CIBMTR Analysis of 5,950 Participants. Transplantation and Cellular Therapy. 2026; 32(2):s260-s261.

Zoref-Lorenz, A; Allen, CE; Behrens, EM; Chandrakasan, S; Chien, M; Hermiston, ML; Hinson, AP; Intzes, S; Isakoff, MS; Leiding, JW; Modica, R; Riskalla, M; Baker, A; Ward, B. Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. Blood advances. 2026; 10(5):1564-1575.